Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2016 | 1 |
2020 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Showing results for
martin s olivo
Your search for
Martina D’Olivo
retrieved no results
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
N Engl J Med. 2021 Apr 22;384(16):1529-1541. doi: 10.1056/NEJMoa2028485.
N Engl J Med. 2021.
PMID: 33882206
Clinical Trial.
Phase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxane.
Kaufman PA, Awada A, Twelves C, Yelle L, Perez EA, Velikova G, Olivo MS, He Y, Dutcus CE, Cortes J.
Kaufman PA, et al. Among authors: olivo ms.
J Clin Oncol. 2015 Feb 20;33(6):594-601. doi: 10.1200/JCO.2013.52.4892. Epub 2015 Jan 20.
J Clin Oncol. 2015.
PMID: 25605862
Free PMC article.
Clinical Trial.
Item in Clipboard
Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to Arms.
Saini KS, de Las Heras B, Plummer R, Moreno V, Romano M, de Castro J, Aftimos P, Fredriksson J, Bhattacharyya GS, Olivo MS, Schiavon G, Punie K, Garcia-Foncillas J, Rogata E, Pfeiffer R, Orbegoso C, Morrison K, Curigliano G, Chin L, Saini ML, Rekdal Ø, Anderson S, Cortes J, Leone M, Dancey J, Twelves C, Awada A.
Saini KS, et al.
JCO Glob Oncol. 2020 Sep;6:1357-1362. doi: 10.1200/GO.20.00346.
JCO Glob Oncol. 2020.
PMID: 32897732
Free PMC article.
No abstract available.
Item in Clipboard
Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate Versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast Cancer.
Twelves C, Awada A, Cortes J, Yelle L, Velikova G, Olivo MS, Song J, Dutcus CE, Kaufman PA.
Twelves C, et al. Among authors: olivo ms.
Breast Cancer (Auckl). 2016 Jun 28;10:77-84. doi: 10.4137/BCBCR.S39615. eCollection 2016.
Breast Cancer (Auckl). 2016.
PMID: 27398025
Free PMC article.
Item in Clipboard
Cite
Cite